This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 17 May 2018  |  North America

    Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

    Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials

    Clinical trial sponsors and clinical research organizations (CROs) are facing intense pressure to change the way clinical research is conducted and justify the costs and time involved in the clinical development process. Some of the prevailing challenges in the clinical trial industry include the complexity and cost of conducting clinical trials, t...

    $3,000.00
  2. 10 May 2018  |  North America

    Global Tissue Diagnostics Market, Forecast to 2022

    Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

    Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...

    $4,950.00
  3. 15 Feb 2018  |  Global

    Global Laboratory Products Purchasing Trends, 2017–2018

    An End User Perspective on Laboratory Spending Reveals Optimism for Growing 2018 Budgets

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in July 2017 that centered around the state of their laboratories in 2017 and their expectations for 2018. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-over...

    $1,500.00
  4. 20 Dec 2017  |  North America

    Strategic Insight into the Global Women’s Healthcare Market, 2017

    Opportunities in Point-of-care (POC) Diagnostics for Cardiology and Oncology, along with Wearables, Stand out in the Market

    Across the world, women typically live longer than men. The reason behind the difference between male and female life expectancy is unclear but could be explained through biological, environmental, and behavioral factors. Because women typically outlive men, they are more likely to suffer from ill health and other age-related diseases. Women’s he...

    $1,500.00
  5. 12 Dec 2017  |  North America

    Growth Insights—Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

    Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

    The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutio...

    $1,500.00
  6. 07 Nov 2017  |  North America

    Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

    Product Diversification, Focus on Therapeutic Plasmapheresis and Pathogen-Reduced Platelets Will Be Key to Success

    The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...

    $1,500.00
  7. 06 Nov 2017  |  South Asia, Middle East & North Africa

    Growth and Investment Opportunities in Nepal Healthcare Market, 2017

    Incidence of Non-Communicable Diseases increasing leading to demand for specialty services

    This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...

    $1,500.00
  8. 31 Oct 2017  |  Global

    Global Digital Pathology Market, 2017 Companies-To-Action

    Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth

    It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...

    $3,000.00
  9. 31 Oct 2017  |  North America

    Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

    A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

    Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in fun...

    $3,000.00
  10. 17 Jul 2017  |  North America

    US Oncology Diagnostics Market, Forecast to 2021

    Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

    Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consoli...

    $4,950.00